UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence

Retrovirology, 2018-01, Vol.15 (1), p.15-15, Article 15

2018

Volltextzugriff (PDF)

Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth

PLoS pathogens, 2016-03, Vol.12 (3), p.e1005472-e1005472

2016

Volltextzugriff (PDF)

Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

Clinical and translational medicine, 2022-01, Vol.12 (1), p.e704-n/a

2022

Volltextzugriff (PDF)

Potent Cell-Intrinsic Immune Responses in Dendritic Cells Facilitate HIV-1-Specific T Cell Immunity in HIV-1 Elite Controllers

PLoS pathogens, 2015-06, Vol.11 (6), p.e1004930-e1004930

2015

Volltextzugriff (PDF)

Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure

Antiviral research, 2010-12, Vol.88 (3), p.281-286

2010

Volltextzugriff (PDF)

A non-infectious cell-based phenotypic assay for the assessment of HIV-1 susceptibility to protease inhibitors

Journal of antimicrobial chemotherapy, 2012-01, Vol.67 (1), p.32-38

2012

Volltextzugriff (PDF)

Correction: Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth

PLoS pathogens, 2016-03, Vol.12 (3), p.e1005532-e1005532

2016

Volltextzugriff (PDF)

The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates

AIDS (London), 2010-01, Vol.24 (1), p.17-25

2010

Volltextzugriff (PDF)

Contribution of Immunological and Virological Factors to Extremely Severe Primary HIV Type 1 Infection

Clinical infectious diseases, 2009-01, Vol.48 (2), p.229-238

2009

Volltextzugriff (PDF)

Combined antiretroviral therapy and immune pressure lead to in vivo HIV-1 recombination with ancestral viral genomes

Journal of acquired immune deficiency syndromes (1999), 2011-06, Vol.57 (2), p.109

2011

Volltextzugriff (PDF)

Effect of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Polymorphism Leu-214 on Replication Capacity and Drug Susceptibility

Journal of Virology, 2009-08, Vol.83 (15), p.7434-7439

2009

Volltextzugriff (PDF)

Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy

mBio, 2021-12, Vol.12 (6), p.e0307821-e0307821

2021

Volltextzugriff (PDF)

Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes

Frontiers in immunology, 2022-09, Vol.13, p.912579-912579

2022

Volltextzugriff (PDF)

Mitochondrial dysfunction, lipids metabolism, and amino acid biosynthesis are key pathways for COVID-19 recovery

iScience, 2023-10, Vol.26 (10), p.107948-107948, Article 107948

2023

Volltextzugriff (PDF)

Treatment with integrase inhibitors alters SARS‐CoV‐2 neutralization levels measured with HIV‐based pseudotypes in people living with HIV

Journal of medical virology, 2023-02, Vol.95 (2), p.e28543-n/a

2023

Volltextzugriff (PDF)

Potent Cell-Intrinsic Immune Responses in Dendritic Cells Facilitate HIV-1-Specific T Cell Immunity in HIV-1 Elite Controllers: e1004930

PLoS pathogens, 2015-06, Vol.11 (6)

2015

Volltextzugriff (PDF)

Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy

Antiviral therapy, 2008-01, Vol.13 (7), p.881-893

2008

Volltextzugriff (PDF)

Dextran sulfate from Leuconostoc mesenteroides B512F exerts potent antiviral activity against SARS-CoV-2 in vitro and in vivo

Frontiers in microbiology, 2023-05, Vol.14, p.1185504-1185504

2023

Volltextzugriff (PDF)

Impact of very early antiretroviral therapy during acute HIV infection on long-term immunovirological outcomes

International journal of infectious diseases, 2023-11, Vol.136, p.100-106

2023

Volltextzugriff (PDF)

Contribution of immunological and virological factors to extremely severe primary HIV-1 infection

Clinical infectious diseases, 2009-01, Vol.48 (2), p.229-238

2009

Volltextzugriff (PDF)

Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells

PLoS pathogens, 2022-01, Vol.18 (1), p.e1010171

2022

Volltextzugriff (PDF)

Pulmonary long-term consequences of COVID-19 infections after hospital discharge

Clinical microbiology and infection, 2021-06, Vol.27 (6), p.892-896

2021

Volltextzugriff (PDF)

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy

Journal of antimicrobial chemotherapy, 2013-10, Vol.68 (10), p.2358-2362

2013

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

SpracheSpanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(47)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence

Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth

Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

Potent Cell-Intrinsic Immune Responses in Dendritic Cells Facilitate HIV-1-Specific T Cell Immunity in HIV-1 Elite Controllers

Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure

A non-infectious cell-based phenotypic assay for the assessment of HIV-1 susceptibility to protease inhibitors

Correction: Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth

The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates

Contribution of Immunological and Virological Factors to Extremely Severe Primary HIV Type 1 Infection

Combined antiretroviral therapy and immune pressure lead to in vivo HIV-1 recombination with ancestral viral genomes

Effect of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Polymorphism Leu-214 on Replication Capacity and Drug Susceptibility

Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy

Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes

Mitochondrial dysfunction, lipids metabolism, and amino acid biosynthesis are key pathways for COVID-19 recovery

Treatment with integrase inhibitors alters SARS‐CoV‐2 neutralization levels measured with HIV‐based pseudotypes in people living with HIV

Potent Cell-Intrinsic Immune Responses in Dendritic Cells Facilitate HIV-1-Specific T Cell Immunity in HIV-1 Elite Controllers: e1004930

Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy

Dextran sulfate from Leuconostoc mesenteroides B512F exerts potent antiviral activity against SARS-CoV-2 in vitro and in vivo

Impact of very early antiretroviral therapy during acute HIV infection on long-term immunovirological outcomes

NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins

Contribution of immunological and virological factors to extremely severe primary HIV-1 infection

Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells

Recommendations for measuring HIV reservoir size in cure-directed clinical trials

Pulmonary long-term consequences of COVID-19 infections after hospital discharge

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy

Aktive Filter

Suchergebnisse filtern